Your browser doesn't support javascript.
Headache medication and the COVID-19 pandemic.
MaassenVanDenBrink, Antoinette; de Vries, Tessa; Danser, A H Jan.
  • MaassenVanDenBrink A; Dept. of Internal Medicine, Division of Pharmacology and Vascular Medicine, Erasmus MC University Medical Center Rotterdam, P.O. Box 2040, 3000, CA, Rotterdam, The Netherlands. a.vanharen-maassenvandenbrink@erasmusmc.nl.
  • de Vries T; Dept. of Internal Medicine, Division of Pharmacology and Vascular Medicine, Erasmus MC University Medical Center Rotterdam, P.O. Box 2040, 3000, CA, Rotterdam, The Netherlands.
  • Danser AHJ; Dept. of Internal Medicine, Division of Pharmacology and Vascular Medicine, Erasmus MC University Medical Center Rotterdam, P.O. Box 2040, 3000, CA, Rotterdam, The Netherlands.
J Headache Pain ; 21(1): 38, 2020 Apr 25.
Article in English | MEDLINE | ID: covidwho-2270138
ABSTRACT
The world is currently dominated by the Corona Virus Disease 2019 (COVID-19) pandemic. Besides the obvious concerns about limitation of virus spread and providing the best possible care to infected patients, a concomitant concern has now arisen in view of a putative link between the use of certain drugs, such as Renin-Angiotensin System (RAS) inhibitors and ibuprofen, and an increased risk for COVID-19 infection. We here discuss this concern in relation to headache treatment and conclude that, based on current evidence, there is no reason to abandon treatment of headache patients with RAS inhibitors or ibuprofen.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Angiotensin-Converting Enzyme Inhibitors / Ibuprofen / Coronavirus Infections / Angiotensin Receptor Antagonists / Headache Type of study: Prognostic study Limits: Humans Language: English Journal: J Headache Pain Journal subject: Internal Medicine / Neurology / Psychophysiology Year: 2020 Document Type: Article Affiliation country: S10194-020-01106-5

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Angiotensin-Converting Enzyme Inhibitors / Ibuprofen / Coronavirus Infections / Angiotensin Receptor Antagonists / Headache Type of study: Prognostic study Limits: Humans Language: English Journal: J Headache Pain Journal subject: Internal Medicine / Neurology / Psychophysiology Year: 2020 Document Type: Article Affiliation country: S10194-020-01106-5